Eli Lilly & Co
LLY· NYSE
Released Apr 27, 2023, before the open
10-Q filed Apr 27, 2023, 27 days after period end · 0000059478-23-000162
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | $6.96B | $7.81B | $6.81B | $5.86B |
| Net Income | $1.34B | $1.90B | $1.36B | $1.46B |
| EPS Diluted |
Eli Lilly & Co · CIK 59478 · Engraved from SEC EDGAR
| $1.49 |
| $2.10 |
| $1.49 |
| $1.60 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.